ORCID

Abstract

The UK government’s five year antimicrobial resistance national action plan will need to tackle the lack of progress and a rapidly declining workforceAntimicrobial resistance (AMR) is one of the most pressing challenges of our time. Resistance to commonly used antimicrobial medicines is already disrupting medicine and adversely affecting patient treatment.1 Efforts have been made internationally to reduce overuse of antimicrobials and to preserve them for future generations, but there is still much to be done. The UK will be at the forefront of these efforts nationally and internationally with its national action plan (NAP)2 that sets out five years of action to support a 20 year vision to tackle antimicrobial resistance collaboratively across borders. But the plan overlooks important aspects of antimicrobial resistance and does not consider the declining AMR workforce.

DOI

10.1136/bmj.q2104

Publication Date

2024-09-26

Publication Title

British Medical Journal

Volume

386

ISSN

0959-8146

First Page

2104

Last Page

2104

Share

COinS